| Literature DB >> 30161178 |
Jin-Woo Kwon1, Sun Young Lee1, Donghyun Jee1, Yang Kyung Cho1.
Abstract
PURPOSE: To determine the prognosis for ocular toxocariasis (OT) according to the location of the granuloma and to identify factors associated with its recurrence within 1 year.Entities:
Mesh:
Year: 2018 PMID: 30161178 PMCID: PMC6117002 DOI: 10.1371/journal.pone.0202904
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1(A) Initial fundus photographs, FAG, and SD-OCT of a 34-year-old male who presented with suddenly decreased vision for 2 days in the right eye. The fundus finding in the right eye shows retinal hemorrhage around the disc edema, multiple retinal granulomatous lesions, and macular edema. Using FAG, there was no abnormal finding except blocked fluorescence at the granuloma and a hemorrhage lesion. SD-OCT shows that granulomas were located across the inner and outer retina. (B) Fundus photograph and SD-OCT at the 3-month recurrence. When compared with the initial visit, larger granulomas accompanying exudation around the lesion were present. (C) Fundus photograph and SD-OCT at 6 months after the initial visit. The location of granulomas changed to the nasal retina, but the ERM remained superior to the fovea. FAG, fluorescein angiography; SD-OCT, spectral domain-optical coherence tomography; ERM, epiretinal membrane.
Comparison of the peripheral granuloma and posterior pole granuloma groups.
| Peripheral granuloma | Posterior pole granuloma | p value | |
|---|---|---|---|
| n | 29 | 18 | |
| Male: female | 22:7 | 16:2 | 0.449 |
| Age (years) | 52.38 ± 10.94 | 54.17 ± 9.17 | 0.677 |
| BCVA (decimal) | 0.583 ± 0.349 | 0.362 ± 0.292 | 0.042 |
| IOP (mmHg) | 15.52 ± 6.05 | 16.17 ± 8.03 | 0.692 |
| Grade of vitreal inflammation (0~4+) | 0.900 ± 0.618 | 1.083 ± 0.862 | 0.551 |
| Grade of anterior inflammation (0~4+) | 0.483 ± 0.688 | 0.333 ± 0.485 | 0.448 |
| BCVA (decimal) | 0.586 ± 0.347 | 0.539 ± 0.305 | 0.673 |
| IOP (mmHg) | 13.45 ± 4.53 | 15.06 ± 3.30 | 0.059 |
| Recurrence within 1 year | 9 (31.03%) | 3 (16.67%) | 0.324 |
| Total IgE (IU/mL) | 390.97 ± 465.06 | 545.44 ± 701.77 | 0.896 |
| Eosinophil counts (/μL) | 182.83 ± 158.95 | 266.72 ± 236.30 | 0.437 |
| Eosinophilia (>500/μL or >5.0% WBC) | 5 (17.24%) | 5 (33.33%) | 0.473 |
| ERM | 4 (13.79%) | 2 (11.11%) | 1.000 |
| CME | 3 (10.34%) | 2 (11.11%) | 1.000 |
| TRD | 11 (37.93%) | 3 (16.67%) | 0.191 |
BCVA, best corrected visual acuity; IOP, intraocular pressure; IgE, immunoglobulin E; WBC, white blood cells; ERM, epiretinal membrane; CME, cystoid macular edema; TRD, tractional retinal detachment.
Fig 2(A) Changes in best corrected visual acuity (BCVA) of the peripheral granuloma group. (B) Changes in BCVA of the posterior pole granuloma group. The BCVA increased after treatment with a significant difference in the posterior pole granuloma group (p = 0.017).
Variables associated with the recurrence of OT-related uveitis within 1 year according to logistic regression analyses.
| Univariate analyses | Multivariate analyses | |||
|---|---|---|---|---|
| Adjusted OR (95%CI) | p value | Adjusted OR (95% CI) | p value | |
| Age | 0.86 (0.77–0.94) | 0.002 | 0.88 (0.79–0.95) | 0.007 |
| BCVA (initial visit, decimal) | 15.64 (1.94–182.43) | 0.016 | 6.70 (0.52–115.97) | 0.154 |
| IOP (initial visit, mmHg) | 1.01 (0.91–1.11) | 0.811 | ||
| Level of IgE (IU/mL) | 1.00 (1.00–1.00) | 0.621 | ||
| Eosinophil counts (/μL) | 1.00 (1.00–1.01) | 0.217 | ||
| Grade of vitreal inflammation (0–4+) | 1.60 (0.66–4.02) | 0.281 | ||
| Grade of anterior inflammation (0–4+) | 1.13 (0.35–3.19) | 0.823 | ||
OR, odds ratio; CI, confidence interval; BCVA, best corrected visual acuity; IOP, intraocular pressure; IgE, immunoglobulin E.
*Adjusted for sex.
a Classified using national institutes of health grading system
b Classified using standardization of uveitis nomenclature working group grading scheme